Elixinol Wellness Limited (EXL.AX)
AUD 0.02
(-10.53%)
AUD 0.02
(-10.53%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -6.8 Million AUD | 37.12% |
| 2022 | -9.28 Million AUD | 34.27% |
| 2021 | -15.5 Million AUD | 36.15% |
| 2020 | -23.35 Million AUD | 3.99% |
| 2019 | -83.49 Million AUD | -15255.33% |
| 2018 | 1.08 Million AUD | 94.48% |
| 2017 | -2.71 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -2.37 Million AUD | 0.0% |
| 2023 Q2 | -3.27 Million AUD | 0.0% |
| 2023 FY | - AUD | 37.12% |
| 2023 Q4 | -2.56 Million AUD | 0.0% |
| 2022 Q4 | -3.63 Million AUD | 0.0% |
| 2022 Q2 | -5.64 Million AUD | 0.0% |
| 2022 FY | - AUD | 34.27% |
| 2021 FY | - AUD | 36.15% |
| 2021 Q4 | -6.31 Million AUD | 0.0% |
| 2021 Q2 | -7.8 Million AUD | 0.0% |
| 2020 Q2 | -14.22 Million AUD | 0.0% |
| 2020 FY | - AUD | 3.99% |
| 2020 Q4 | -7.89 Million AUD | 0.0% |
| 2019 Q2 | -11.43 Million AUD | 0.0% |
| 2019 FY | - AUD | -15255.33% |
| 2019 Q4 | -9.88 Million AUD | 0.0% |
| 2018 Q4 | -22.02 Million AUD | 0.0% |
| 2018 Q1 | 81.75 Thousand AUD | 0.0% |
| 2018 FY | - AUD | 94.48% |
| 2018 Q2 | 701 Thousand AUD | 757.49% |
| 2017 Q4 | 81.75 Thousand AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Althea Group Holdings Limited | -28.56 Million AUD | 76.17% |
| Cann Group Limited | -35.53 Million AUD | 80.848% |
| ECS Botanics Holdings Ltd | 3.22 Million AUD | 310.823% |
| Ecofibre Limited | -38.34 Million AUD | 82.25% |
| Hygrovest Limited | -1.1 Million AUD | -517.044% |
| IDT Australia Limited | -5.13 Million AUD | -32.593% |
| Invion Limited | -4.57 Million AUD | -48.871% |
| Little Green Pharma Ltd | -4.64 Million AUD | -46.576% |
| Live Verdure Ltd | -12.51 Million AUD | 45.602% |
| Medical Developments International Limited | -29.44 Million AUD | 76.887% |
| Vitura Health Limited | 7.07 Million AUD | 196.181% |
| Vita Life Sciences Limited | 13.09 Million AUD | 151.962% |